BISACODYL (BRD-K39987650)
Overview
- pert_id
- BRD-K39987650
- Name
- bisacodyl
- Collection
- BIOA
- MOA
- laxative
- Target(s)
- Unknown
- Indication(s)
- constipation
- Phase
- Launched
- Canonical SMILES
- CC(=O)Oc1ccc(cc1)C(c2ccc(OC(=O)C)cc2)c3ccccn3
- InChI key
- InChIKey=KHOITXIGCFIULA-UHFFFAOYSA-N
- InChI string
- InChI=1S/C22H19NO4/c1-15(24)26-19-10-6-17(7-11-19)22(21-5-3-4-14-23-21)18-8-12-20(13-9-18)27-16(2)25/h3-14,22H,1-2H3
- Molecular formula
- C22H19NO4
- Molecular weight
- 361.391
External links
- PubChem
- 2391
- Wikipedia
- http://en.wikipedia.org/wiki/Bisacodyl
- SEP-L1000
- BRD-K39987650
Predicted MOAs
| MOA | Probability |
|---|---|
| cyclooxygenase inhibitor | 0.5604 |
| calcium channel blocker | 0.1064 |
| protein synthesis inhibitor | 0.0526 |
| retinoid receptor agonist | 0.0311 |
| estrogen receptor agonist | 0.0285 |
| tubulin polymerization inhibitor | 0.0273 |
| HDAC inhibitor | 0.0167 |
| MEK inhibitor | 0.0150 |
| PARP inhibitor | 0.0146 |
| topoisomerase inhibitor | 0.0139 |
Chemical structure
Diagnoses (based on Mount Sinai EHR)
Top diagnoses associated with bisacodyl:
Co-prescribed Drugs (based on Mount Sinai EHR)
Top coprescribed drugs of bisacodyl:
Age Distribution (based on Mount Sinai EHR)
Probability distribution for the prescription of bisacodyl across different ages: